EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Idiopathic Pulmonary Fibrosis: An Overview

James May, Gisli Jenkins

British Journal of Hospital Medicine · 09.02.2026 · 87 (2)

DOI: 10.31083/bjhm50844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 09.02.2026. Verfasst von James May und 1 weiteren Autor:innen. Beteiligte Einrichtung: Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, SW3 6LY London, UK. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Institute for Health and Care Research, MRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is the prototypical fibrosing interstitial lung disease, characterised by its unrelenting progressive course and poor prognosis. The incidence of IPF is rising and is becoming a major public health concern. Debilitating dyspnoea and respiratory failure results. Death occurs on average 3–5 years from the time of diagnosis. Clearer understanding of the pathobiology of the condition continues to advance and although we may now better understand disease mechanisms, our therapeutic approach remains limited. In the UK, only two treatments are licensed for IPF, and both can only slow the process down. An ideal silver bullet would halt and ideally reverse established fibrosis. New therapies are showing promise; however, lung transplant remains the only treatment that can substantially increase both duration and quality of life. Here we will provide a comprehensive overview of IPF to summarise definitions, epidemiology, mechanisms, diagnostics, and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisHumansLung TransplantationRisk FactorsPrognosis

Stichwörter der Autor:innen

diagnosisidiopathic pulmonary fibrosismanagementoutcomesrisk factors

Autor:innen und Institutionen

  • Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, SW3 6LY London, UK.

Förderung

  • Medical Research Council
  • National Institute for Health and Care Research
  • MRC

Zitieren

APA

May, J., & Jenkins, G. (2026). Idiopathic Pulmonary Fibrosis: An Overview. British Journal of Hospital Medicine, 87(2). https://doi.org/10.31083/bjhm50844

Vancouver

May J, Jenkins G. Idiopathic Pulmonary Fibrosis: An Overview. British Journal of Hospital Medicine. 2026;87(2). doi:10.31083/bjhm50844

BibTeX
@article{May2026,
  author = {May, James and Jenkins, Gisli},
  title = {Idiopathic Pulmonary Fibrosis: An Overview},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {2},
  doi = {10.31083/bjhm50844}
}
Kostenlos starten →